You have read all your free articles, to continue reading subscribe to read the rest of this content.
The collaboration, announced in August, is one of the broadest partnerships within the U.S. biosimilar industry to date to accelerate improved patient access for high quality biosimilar medicines in the U.S. biosimilar industry. Alvotech and Teva Pharmaceutical Industries have entered into an excAlready a subscriber Login You have read all…
Johnson & Johnson’s Janssen Pharmaceutical Companies plan to invest $10 million in a new UK government-led global dementia discovery fund for research to find ways to prevent and treat dementia and Alzheimer's disease. The investment will come through its affiliate venture arm, Johnson & JAlready a subscriber Login You have…
Alvotech and Oaktree Acquisition Corp II establish financing facilities to enhance the company’s capital position and to replace any redeemed capital as part of their proposed merger. The two parties agree to reduce the minimum cash condition outlined in the merger agreement, thereby enhancing Already a subscriber Login You have…
Researchers have published findings about estrogen receptor status, treatment and breast cancer prognosis in Icelandic BRCA2 mutation carriers. The impact of an inherited BRCA2 mutation on the prognosis of women with breast cancer has not been well documented. The researchers studied the effects Already a subscriber Login You have read…
